Community/Retail

This month's OTC product new features, eye drops, hemp oil for dogs, and daily supplement packs.

Pharmacists can offer medication adherence and management counseling and help patients with chronic disease treatments.

Depression can make people who have recovered from COVID-19 feel less enthusiastic in their daily lifestyle.

Ruxolitinib (Opzelura) is indicated for the topical short-term and non-continuous chronic treatment of mild to moderate atopic dermatitis.

Kaopectate treats diarrhea, heartburn, nausea, and upset stomach.

Three in 5 say it is hard to get kids to eat well-balanced diets, because of not eating enough fruits and vegetables, pickiness, and other reasons.

FDA-approved Disulfiram can safely reduce anxiety levels in rodents, analysis from the Tokyo University of Sciences and other Japan institutes finds.

On this week's episode, Suzy is joined by Michelle Henry, MD, from Skin & Aesthetic Surgery of Manhattan, a board-certified dermatologist located in New York.

The first cases were identified in October 2021 at a children’s hospital in Alabama that admitted 5 children with significant liver injury, including some with acute liver failure.

New analysis demonstrates that physical activity improves cognitive health, thus staving off dementia.

32 public colleges with combined enrollment of more than 700,000 students must comply with law by January 2023.

Pilocarpine (Vuity) is a cholinergic muscarinic receptor agonist indicated for the treatment of presbyopia in adults.

PinkEye Relief are sterile eye drops that temporarily relieve burning, swelling, and crusting.

The CIC is a combination of Novavax’s COVID-19 vaccine, NVX-CoV2373, and its quadrivalent influenza vaccine candidate.

Each time a pharmacist immunizes a patient against one of the 27 infections for which a safe and effective vaccine exists, the profession continues to protect communities against diseases that wreaked havoc on generations.

The application is based on positive results from the ASCEND phase 3 clinical trial, assessing the efficacy and safety of daprodustat for the treatment of anemia from chronic kidney disease.

Evusheld has been found to significantly reduce the risk of developing symptomatic COVID-19.

Analysis indicates that quitting provides roughly the same benefit as taking 3 medications together.

US segment to hit $121.8 billion in 2022, notes market research firm.

Among Black and Latina women with heart failure, negative health outcomes are magnified due to significant health disparities and inequities in the management of the chronic condition.

Premsyn PMS temporarily relieves symptoms associated with premenstrual syndrome.

Proactive retention strategies can improve employee satisfaction and reduce turnover rates.

Sonia Oskouei, PharmD, vice president of biosimilars at Cardinal Health, discusses what biosimilars in the pipeline are expected to launch this year.

Asthma contributed most to the risk of high blood pressure and coronary heart disease.

Among individuals taking the medication with standard-of-care topical corticosteroids, approximately 41% achieved clear or almost clear skin at 16 weeks.

Sonia Oskouei, PharmD, vice president of biosimilars at Cardinal Health, on the results of Cardinal Health’s assessment of the current biosimilars market published in the 2022 Biosimilars Report.

Although the ISMP created the guidelines for hospitals, they are applicable in other health care settings.

The phase 3, multicenter, randomized, double-blinded, comparative clinical study was evaluating the efficacy and safety of ABP 654 compared with ustekinumab in adult patients with moderate to severe plaque psoriasis.